Our Team


We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care.

Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients.

  • Leadership
  • Board of Directors
  • Medical & Scientific
  • Scientific Advisory Board
Mark Mallon
Chief Executive Officer and Member of the Board of Directors
Read Bio
William Bonello
Chief Financial Officer
Read Bio
George A. Cardoza
President and Chief Operating Officer, Laboratory Operations
Read Bio
Gina Wallar, PhD, MPH
President, Pharma Services Division
Read Bio
Clive Morris
Clive Morris, MD, MBA
President at Inivata
Read Bio
Kathryn B. McKenzie
Chief Sustainability and Risk Officer
Read Bio
Jennifer M. Balliet
Chief Culture Officer
Read Bio
John Mooney
Chief Technology Officer
Read Bio
Halley Gilbert profile image
Halley Gilbert
Chief Legal Officer
Read Bio
Douglas Brown
Chief Strategy and Corporate Development Officer
Read Bio
Marcus B. Silva, JD, MBA
Chief Marketing Officer
Read Bio
Steven G. Brodie, PhD FACMG
Senior Vice President, Laboratory Operations
Read Bio